redirect to https://www.japantimes.co.jp/news/2023/09/25/japan/science%2Dhealth/national%2Dlecanemab%2Dapproval/<script>window.location.href = 'mailto:?subject=as japan oks alzheimer&#39;s drug, issue of side effects comes into focus&body=https://www.japantimes.co.jp/news/2023/09/25/japan/science%2Dhealth/national%2Dlecanemab%2Dapproval/';setTimeout(function(){window.location.href= 'https://www.japantimes.co.jp/news/2023/09/25/japan/science%2Dhealth/national%2Dlecanemab%2Dapproval/'},500);</script>